{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:32:22Z","timestamp":1778452342872,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cld.2023.07.004","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T15:17:53Z","timestamp":1693063073000},"page":"115-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Systemic Complications of Primary Biliary Cholangitis"],"prefix":"10.1016","volume":"28","author":[{"given":"Mariana","family":"Zapata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrick","family":"Pagan-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlyn J.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cld.2023.07.004_bib1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.abd.2021.06.007","article-title":"Cholestatic pruritus: a knowledge update","volume":"97","author":"Nietsche","year":"2022","journal-title":"An Bras Dermatol"},{"issue":"6","key":"10.1016\/j.cld.2023.07.004_bib2","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.jaad.2020.04.183","article-title":"Prurigo nodularis: epidemiology and clinical features","volume":"83","author":"Huang","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.cld.2023.07.004_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41575-022-00687-7","article-title":"Mechanisms of pruritus in cholestasis: understanding and treating the itch","volume":"20","author":"Beuers","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.07.004_bib4","first-page":"75","article-title":"Cholestatic pruritus : an update","volume":"82","author":"De Vloo","year":"2019","journal-title":"Acta Gastroenterol Belg"},{"issue":"3","key":"10.1016\/j.cld.2023.07.004_bib5","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2010.05.009","article-title":"Lysophosphatidic acid is a potential mediator of cholestatic pruritus","volume":"139","author":"Kremer","year":"2010","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2023.07.004_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2023.07.004_bib7","first-page":"CD000551","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","volume":"12","author":"Rudic","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2023.07.004_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2023.02.005","article-title":"New treatment paradigms in primary biliary cholangitis","author":"Levy","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2023.07.004_bib9","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2020.10.001","article-title":"Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double-blind, randomized, placebo-controlled trial","volume":"160","author":"de Vries","year":"2021","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2023.07.004_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"Electronic address eee, European association for the study of the L. EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.07.004_bib11","article-title":"GLIMMER: a randomized phase 2b dose-ranging trial of linerixibat in primary biliary cholangitis patients with pruritus","author":"Levy","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10311","key":"10.1016\/j.cld.2023.07.004_bib12","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(21)01256-3","article-title":"Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study","volume":"398","author":"Gonzales","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.cld.2023.07.004_bib13","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","article-title":"Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial","volume":"7","author":"Thompson","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2023.07.004_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4254\/wjh.v14.i6.1111","article-title":"Understanding fatigue in primary biliary cholangitis: from pathophysiology to treatment perspectives","volume":"14","author":"Lynch","year":"2022","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.07.004_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.07.004_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2023.07.004_bib17","first-page":"21","article-title":"Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management","volume":"17","author":"Kosnik","year":"2022","journal-title":"Prz Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2023.07.004_bib18","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1097\/MJT.0000000000000387","article-title":"A\u00a0randomized, placebo-controlled clinical trial of efficacy and safety: modafinil in the treatment of fatigue in patients with primary biliary cirrhosis","volume":"24","author":"Silveira","year":"2017","journal-title":"Am J Ther"},{"issue":"3","key":"10.1016\/j.cld.2023.07.004_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/cld.901","article-title":"Managing the symptoms and complications of cholestasis","volume":"15","author":"Pedersen","year":"2020","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2023.07.004_bib20","first-page":"82","article-title":"Osteoporosis in primary biliary cirrhosis of the liver","volume":"9","author":"Raszeja-Wyszomirska","year":"2014","journal-title":"Prz Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2023.07.004_bib21","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1172\/JCI117959","article-title":"Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice","volume":"95","author":"Janes","year":"1995","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.cld.2023.07.004_bib22","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/hep.24605","article-title":"Effects of bilirubin and sera from jaundiced patients on osteoblasts: contribution to the development of osteoporosis in liver diseases","volume":"54","author":"Ruiz-Gaspa","year":"2011","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2023.07.004_bib23","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/liv.12153","article-title":"Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells","volume":"33","author":"Dubreuil","year":"2013","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.cld.2023.07.004_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cld.2018.03.014","article-title":"Chronic complications of cholestasis: evaluation and management","volume":"22","author":"Assis","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2023.07.004_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"American association of clinical endocrinologists\/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.cld.2023.07.004_bib26","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1007\/s12072-022-10366-z","article-title":"Two-year risedronate treatment for osteoporosis in patients with esophageal varices: a non-randomized clinical trial","volume":"16","author":"Santos","year":"2022","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.cld.2023.07.004_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/gut.51.2.265","article-title":"Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis","volume":"51","author":"Longo","year":"2002","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cld.2023.07.004_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.dld.2011.07.020","article-title":"Serum lipids in primary sclerosing cholangitis","volume":"44","author":"Sinakos","year":"2012","journal-title":"Dig Liver Dis"},{"issue":"11","key":"10.1016\/j.cld.2023.07.004_bib29","first-page":"e31411","article-title":"Hyperlipidemia in the setting of primary biliary cholangitis: a case report and review of management strategies","volume":"14","author":"Ahoussougbemey Mele","year":"2022","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.cld.2023.07.004_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/MED.0000000000000466","article-title":"Controversy over the atherogenicity of lipoprotein-X","volume":"26","author":"Miida","year":"2019","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"10.1016\/j.cld.2023.07.004_bib31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.numecd.2018.09.006","article-title":"Lipoprotein-X fifty years after its original discovery","volume":"29","author":"Fellin","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.cld.2023.07.004_bib32","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1172\/JCI108393","article-title":"Formation of lipoprotein-X. Its relationship to bile compounds","volume":"57","author":"Manzato","year":"1976","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.cld.2023.07.004_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123046","article-title":"Features of lipid metabolism disorders in primary biliary cholangitis","volume":"10","author":"Reshetnyak","year":"2022","journal-title":"Biomedicines"},{"issue":"10003","key":"10.1016\/j.cld.2023.07.004_bib34","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2023.07.004_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jdcr.2020.10.029","article-title":"Diffuse xanthomas in a patient with primary biliary cholangitis and lipoprotein X","volume":"7","author":"Harris","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"5","key":"10.1016\/j.cld.2023.07.004_bib36","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.1840150518","article-title":"Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?","volume":"15","author":"Crippin","year":"1992","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2023.07.004_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12876-021-01974-4","article-title":"The liver steatosis severity and lipid characteristics in primary biliary cholangitis","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2023.07.004_bib38","first-page":"119","article-title":"Risk of cardiovascular events in patients with primary biliary cholangitis - systematic review","volume":"6","author":"Suraweera","year":"2018","journal-title":"J\u00a0Clin Transl Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2023.07.004_bib39","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/hepr.12452","article-title":"Coronary artery disease in primary biliary cirrhosis: a systematic review and meta-analysis of observational studies","volume":"45","author":"Ungprasert","year":"2015","journal-title":"Hepatol Res"},{"issue":"3","key":"10.1016\/j.cld.2023.07.004_bib40","doi-asserted-by":"crossref","first-page":"e33442","DOI":"10.1371\/journal.pone.0033442","article-title":"Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden","volume":"7","author":"Zoller","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2023.07.004_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/00365529409103621","article-title":"Effects of ursodeoxycholic acid on plasma lipids","volume":"204","author":"Angelin","year":"1994","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"3","key":"10.1016\/j.cld.2023.07.004_bib42","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American association for the study of liver diseases","volume":"74","author":"Lai","year":"2021","journal-title":"Hepatology"},{"issue":"4 Pt B","key":"10.1016\/j.cld.2023.07.004_bib43","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.bbadis.2017.12.039","article-title":"Heart and bile acids - clinical consequences of altered bile acid metabolism","volume":"1864","author":"Vasavan","year":"2018","journal-title":"Biochim Biophys Acta, Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.cld.2023.07.004_bib44","doi-asserted-by":"crossref","first-page":"e12925","DOI":"10.1111\/anec.12925","article-title":"QTc interval prolongation in the patients with primary biliary cholangitis","volume":"27","author":"Wang","year":"2022","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"5","key":"10.1016\/j.cld.2023.07.004_bib45","doi-asserted-by":"crossref","first-page":"G764","DOI":"10.1152\/ajpgi.00501.2009","article-title":"Impaired cardiovascular function in primary biliary cirrhosis","volume":"298","author":"Jones","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"10.1016\/j.cld.2023.07.004_bib46","doi-asserted-by":"crossref","first-page":"e0194397","DOI":"10.1371\/journal.pone.0194397","article-title":"Cardiac involvement in patients with primary biliary cholangitis: a 14-year longitudinal survey-based study","volume":"13","author":"Bian","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cld.2023.07.004_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/biom8040159","article-title":"Overview of bile acids signaling and perspective on the signal of ursodeoxycholic acid, the most hydrophilic bile acid, in the heart","volume":"8","author":"Hanafi","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.cld.2023.07.004_bib48","doi-asserted-by":"crossref","first-page":"3432640","DOI":"10.1155\/2016\/3432640","article-title":"Risk and surveillance of cancers in primary biliary tract disease","volume":"2016","author":"Hrad","year":"2016","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"10.1016\/j.cld.2023.07.004_bib49","first-page":"266","article-title":"Increased cancer risk in a large population-based cohort of patients with primary biliary cirrhosis: follow-up for up to 36 years","volume":"8","author":"Boonstra","year":"2014","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.cld.2023.07.004_bib50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cld.2012.11.005","article-title":"Care of the cholestatic patient","volume":"17","author":"Gossard","year":"2013","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2023.07.004_bib51","doi-asserted-by":"crossref","first-page":"G31","DOI":"10.1152\/ajpgi.00536.2002","article-title":"Bile acids activate EGF receptor via a TGF-alpha-dependent mechanism in human cholangiocyte cell lines","volume":"285","author":"Werneburg","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11","key":"10.1016\/j.cld.2023.07.004_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/life11111200","article-title":"Cholemic nephropathy as cause of acute and chronic kidney disease. Update on an under-diagnosed disease","volume":"11","author":"Tinti","year":"2021","journal-title":"Life"},{"issue":"6","key":"10.1016\/j.cld.2023.07.004_bib53","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/ckj\/sfw085","article-title":"Primary sclerosing cholangitis: a new cause of distal renal tubular acidosis","volume":"9","author":"Goutaudier","year":"2016","journal-title":"Clin Kidney J"},{"issue":"48","key":"10.1016\/j.cld.2023.07.004_bib54","doi-asserted-by":"crossref","first-page":"e13172","DOI":"10.1097\/MD.0000000000013172","article-title":"Primary biliary cirrhosis with refractory hypokalemia: a case report","volume":"97","author":"Dong","year":"2018","journal-title":"Medicine (Baltim)"},{"issue":"5","key":"10.1016\/j.cld.2023.07.004_bib55","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.1840110504","article-title":"Sjogren's syndrome in patients with primary biliary cirrhosis","volume":"11","author":"Tsianos","year":"1990","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.07.004_bib56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jtos.2014.12.001","article-title":"Clinical guidelines for management of dry eye associated with Sjogren disease","volume":"13","author":"Foulks","year":"2015","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.cld.2023.07.004_bib57","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cger.2016.08.007","article-title":"Sjogren syndrome and other causes of sicca in older adults","volume":"33","author":"Baer","year":"2017","journal-title":"Clin Geriatr Med"},{"issue":"8179","key":"10.1016\/j.cld.2023.07.004_bib58","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(80)91621-9","article-title":"Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host disease","volume":"1","author":"Epstein","year":"1980","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cld.2023.07.004_bib59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00918090","article-title":"Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases","volume":"12","author":"Zurgil","year":"1992","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"10.1016\/j.cld.2023.07.004_bib60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.510310106","article-title":"Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis","volume":"31","author":"Reynoso-Paz","year":"2000","journal-title":"Hepatology"},{"issue":"4 Pt 1","key":"10.1016\/j.cld.2023.07.004_bib61","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/hep.1840200418","article-title":"Human combinatorial autoantibodies and mouse monoclonal antibodies to PDC-E2 produce abnormal apical staining of salivary glands in patients with coexistent primary biliary cirrhosis and Sjogren's syndrome","volume":"20","author":"Tsuneyama","year":"1994","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.07.004_bib62","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40744-017-0074-2","article-title":"Chronic autoimmune epithelitis in sjogren's syndrome and primary biliary cholangitis: a comprehensive review","volume":"4","author":"Selmi","year":"2017","journal-title":"Rheumatol Ther"},{"issue":"2","key":"10.1016\/j.cld.2023.07.004_bib63","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archinte.159.2.174","article-title":"Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group","volume":"159","author":"Vivino","year":"1999","journal-title":"Arch Intern Med"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:59:32Z","timestamp":1761069572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326123000843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1089326123000843"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2023.07.004","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Complications of Primary Biliary Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2023.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}